The diagnostic value of CLL-1 is discussed controversially: while Zhang et al. showed that CLL-1 was increased after chemotherapy (371), others showed that there is no difference between CLL-1 expression at diagnosis and at relapse (415) or even detected a decreased CLL-1 expression at relapse (370). The gene discussed is CLEC12A; the disease is B-cell chronic lymphocytic leukemia.